Side-by-side comparison of AI visibility scores, market position, and capabilities
$285M revenue 2024; $225M ARR (+12.5% YoY slowdown); $6.3B valuation; $1.3B total funding; 850 customers; 969 employees; AutoML market $1B 2023 to $6.4B 2028 (+45% CAGR); enterprise AI platform
DataRobot is an enterprise AI and machine learning platform company founded in 2012 in Boston by Jeremy Achin and Tom de Godoy. The company pioneered the AutoML category, with a mission to democratize AI by automating the model development lifecycle so that data scientists, analysts, and business users at any organization could build, deploy, and monitor predictive models without requiring deep ML expertise for every step.\n\nDataRobot's platform covers the full AI lifecycle: automated feature engineering and model training across dozens of algorithms, model explainability and bias detection, one-click deployment to production, and continuous monitoring for model drift and data quality degradation. The company has expanded beyond AutoML into a broader AI platform that supports generative AI use cases, LLM evaluation, and AI governance workflows. DataRobot serves more than 850 enterprise customers across financial services, healthcare, manufacturing, and the public sector, with use cases spanning credit risk modeling, demand forecasting, predictive maintenance, and clinical decision support.\n\nDataRobot reported $285 million in revenue for 2024, with $225 million in ARR, and carries a $6.3 billion valuation on $1.3 billion in total funding. The company has navigated multiple leadership transitions and repositioning efforts, ultimately establishing itself as a durable enterprise AI platform. Its depth of AutoML capabilities, enterprise governance features, and broad deployment integrations keep it competitive against both specialist ML platforms and the AI tools embedded in major cloud providers.
AI training data platform with $14B valuation; human-labeled datasets for OpenAI, Anthropic, and DOD plus LLM evaluation tools as critical AI infrastructure competing with Appen.
Scale AI is an AI data platform providing data labeling, data curation, and AI evaluation services that power the training and fine-tuning of AI models for major technology companies, autonomous vehicle developers, and government agencies. Founded in 2016 by Alexandr Wang and Lucy Guo in San Francisco, Scale AI has raised approximately $1.5 billion at a $14 billion valuation and generates substantial revenue from contracts with AI labs (OpenAI, Anthropic, Meta AI), government defense clients (US Department of Defense), and enterprise AI teams needing high-quality training data.\n\nScale AI's core service is human-in-the-loop data labeling — providing labeled datasets (annotated images, transcribed and labeled conversations, validated code outputs) that AI models need for training and evaluation. Scale's platform combines AI-assisted pre-labeling with human quality verification, reducing the cost of producing labeled data while maintaining accuracy standards. Scale Spellbook provides API-based LLM evaluation and comparison tools. Scale's Government division has grown significantly, providing AI evaluation and training data services to US defense and intelligence agencies.\n\nIn 2025, Scale AI is one of the most strategically positioned companies in the AI infrastructure stack — as AI labs compete to train frontier models, the quality and volume of training data has become a critical competitive variable. Scale's defense contracts have expanded significantly under the Biden and Trump administrations'AI strategy initiatives. Scale competes with Appen, Surge AI, and cloud provider-native labeling services for AI training data. The 2025 strategy focuses on expanding its government and defense business, launching Scale's Frontier Data for synthetic data generation to supplement human-labeled data, and growing its enterprise AI deployment services for Fortune 500 companies building production AI systems.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.